Social determinants of von willebrand factor: The whitehall II study

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 20, Issue 7, 2000, Pages 1842-1847

  Kumari, Meena ^a,b   Marmot, Michael ^a   Brunner, Eric ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Metabolic syndrome; Smoking; Socioeconomic status; Von Willebrand factor

Indexed keywords

ALCOHOL; FIBRINOGEN; GLUCOSE; VON WILLEBRAND FACTOR;

ALCOHOL CONSUMPTION; ARTICLE; CARDIOVASCULAR RISK; CIGARETTE SMOKING; CONTROLLED STUDY; EMPLOYMENT; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; SOCIAL CLASS; TOBACCO;

EID: 0033927660     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.20.7.1842     Document Type: Article

References (27)

1. Blane D, Brunner EJ, Wilkinson RG. Health and Social Organization. London, England: Routledge; 1996:1-326.
2. Marmot MG, Davey Smith G, Stansfeld SA, Patel C, North F, Head J, White I, Brunner EJ, Feeney A. Health inequalities among British Civil Servants: the Whitehall II study. Lancet. 1991;337:1387-1393.
3. Marmot MG, Shipley MJ, Rose G. Inequalities in death: specific explanations of a general pattern. Lancet. 1984;1:1003-1006.
4. Marmot MG, Bosma H, Hemingway H, Brunner E, Stansfeld S. Contribution of job control and other risk factors to social variations in coronary heart disease incidence. Lancet. 1997;350:235-239.
5. Brunner EJ, Davey Smith G, Marmot MG, Canner R, Beksinska M, O'Brien J. Childhood social circumstances and psychosocial and behavioural factors as determinants of plasma fibrinogen. Lancet. 1996;347: 1008-1013.
6. Brunner EJ, Marmot MG, Nanchahal K, Shipley MJ, Stansfeld SA, Juneja M, Alberti KGMM. Social inequality in coronary risk: central obesity and the metabolic syndrome: evidence from the Whitehall II study. Diabetologia. 1997;40:1341-1349.
7. Boneu B, Abbal M, Plante J, Bierme R. Factor VIII complex and endothelial damage. Lancet. 1975;1:1430.
8. O'Brien JR. Shear-induced platelet aggregation. Lancet. 1990;335: 711-713.
9. Ruggeri ZM. Cell adhesion in vascular biology: von Willebrand Factor. J Clin Invest. 1997;99:559-564.
10. Lufkin EG, Fass DN, O'Fallon WM, Bowie EJ. Increased von Willebrand factor in diabetes mellitus. Metabolism. 1979;28:63-66.
11. Conlan MG, Folsom AR, Finch A, Davis CE, Sorlie P, Marcucci G, Wu KK. Associations of Factor VIII and von Willebrand factor with age, race, sex, and risk factors for atherosclerosis: the Atherosclerosis Risk in Communities (ARIC) Study. Thromb Haemost. 1993;70:380-385.
12. Rumley A, Lowe GD, Sweetnam PM, Yarnell JW, Ford RP. Factor VIII, von Willebrand factor and the risk of major ischaemic heart disease in the Caerphilly Heart Study. Br J Haematol. 1999;105:110-116.
13. Folsom AR, Wu KK, Rosamond WD, Sharett AR, Chambless LE. Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) study. Circulation. 1997;96:1102-1108.
14. Beksinska M, Yea L, Brunner EJ. Whitehall II Study Manual for Screening Examination 1991-93. London, England: Department of Epidemiology and Public Health, University College London; 1995.
15. WHO Study Group Diabetes Mellitus. Report of a WHO Study Group. Geneva, Switzerland: World Health Organization; 1985.
16. Markowe HLJ, Marmot MG, Shipley MJ, Bulpitt CJ, Meade TW, Stirling Y, Vickers MV, Semmence A. Fibrinogen: a possible link between social class and coronary heart disease. Br Med J. 1985;291:1312-1314.
17. Mannucci PM. Von Willebrand factor: a marker of endothelial damage. Arterioscler Thromb Vasc Biol. 1998;18:1359-1362.
18. Pearson JD. The control of production and release of haemostatic factors in the endothelial cell. Bailliere's Clin Haem. 1993;6:1359-1362.
19. Pearson JD. Markers of endothelial perturbation and damage. Br J Rheum. 1993;32:651-652.
20. Marmot MG, Rose G, Shipley M, Hamilton PJS. Employment grade and coronary heart disease in British civil servants. J Epidemiol Commun Health. 1978;32:244-249.
21. DePergola G, DeMitrio V, Giorgino F, Sciarattia M, Minenna A, Di-Beri L, Pannacciulli N, Giorgino R. Increase in both pro-thrombotic and anti-thrombotic factors in obese pre-menopausal women: relationship with body fat distribution. Int J Obes Relat Metab Disord. 1997;21: 527-535.
22. Iso H, Jacobs DR, Wentworth D, Neaton JD, Cohen JD. Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the Multiple Risk Factor Intervention Trial. N Engl J Med. 1989;320: 904-910.
23. Blann AD, Kirkpatrick U, Devine C, Naser S, McCollum CN. The influence of acute smoking on leucocytes, platelets and the endothelium. Atherosclerosis. 1998;141:133-139.
24. Smith FB, Lowe GD, Fowkes FG, Rumley A, Rumley AG, Donnan PT, Houslay E. Smoking, haemostatic factors and lipid peroxides in a population case control study of peripheral arterial disease. Atherosclerosis. 1993;102:155-162.
25. Blann AD, McCollum CN. Adverse influence of cigarette smoking on the endothelium. Thromb Haemost. 1993;70:707-711.
26. Marmot MG, Brunner EJ. Alcohol and cardiovascular disease: the status of the U shaped curve. Br Med J. 1991;303:565-568.
27. Wamala SP, Murray MA, Horsten M, Schenk-Gustafsson K, Hamsten A, Silveira A, Orth-Gomer K. Socioeconomic status and determinants of hemostatic function in healthy women. Arterioscler Thromb Vasc Biol. 1999;19:485-492.